Truist lifts PT on Teva Pharmaceutical Industries (TEVA) to $36 from $32

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best performing pharma stocks in 2025. Truist lifted the ...
Seeking Alpha

Why PPH Keeps Working When Single Themes Break

The VanEck Pharmaceutical ETF offers concentrated exposure to large-cap global pharma leaders, balancing growth, defensive, and non-drug cash flow stabilizers. PPH has demonstrated resilience, ...

Peak Pharma - Is it time to rethink our pharmaceutical innovation system?

A full professor of markets, organisations and society at UCD, Prof Geiger is a leading international expert on ...
Morningstar

AlzeCure Pharma to present at Redeye Theme: Alzheimer & Parkinsons on April 8

STOCKHOLM, SE / ACCESS Newswire / April 1, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...

IT may be dark horse of 2026; realty, pharma and capex also in focus: Sunil Subramaniam

Nifty IT could emerge as a contrarian winner in 2026 as rupee depreciation, AI-led consulting demand and expected Fed rate cuts boost earnings, says Sunil Subramaniam. He also sees strong recovery ...

Indian pharma’s defining year: Navigating disruption and preparing for a new global order

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation. Over the past decade, Indian drugmakers have pursued selective, high-impact ...